UM

Browse/Search Results:  1-5 of 5 Help

Selected(0)Clear Items/Page:    Sort:
Cost-utility analysis of newborn hepatitis B immunization in Beijing Journal article
Guo, Yiwei, Yang, Yong, Bai, Qian, Huang, Zhengwei, Wang, Zongwu, Cai, Dongxia, Li, Shuo, Man, Xiaowei, Shi, Xuefeng. Cost-utility analysis of newborn hepatitis B immunization in Beijing[J]. Human Vaccines and Immunotherapeutics, 2020, 17(4), 1196-1204.
Authors:  Guo, Yiwei;  Yang, Yong;  Bai, Qian;  Huang, Zhengwei;  Wang, Zongwu; et al.
Favorite | TC[WOS]:3 TC[Scopus]:4  IF:4.1/4.2 | Submit date:2022/05/13
Beijing  Cost-utility  Economic Evaluation  Hepatitis b  Vaccination  
Emerging trends and new developments in monoclonal antibodies: A scientometric analysis (1980–2016) Journal article
Lai,Yunfeng, Wang,Ruibing, Chen,Xin, Tang,Daisheng, Hu,Yuanjia, Cai,Jing, Zhang,Qingwen, Hu,Hao. Emerging trends and new developments in monoclonal antibodies: A scientometric analysis (1980–2016)[J]. Human Vaccines and Immunotherapeutics, 2017, 13(6), 1388-1397.
Authors:  Lai,Yunfeng;  Wang,Ruibing;  Chen,Xin;  Tang,Daisheng;  Hu,Yuanjia; et al.
Favorite | TC[WOS]:16 TC[Scopus]:22  IF:4.1/4.2 | Submit date:2021/03/01
Citespace  Intellectual Landscape  Mab  Monoclonal Antibody  Scientometric  
Research and development of therapeutic mAbs: An analysis based on pipeline projects Journal article
Geng X., Kong X., Hu H., Chen J., Yang F., Liang H., Chen X., Hu Y.. Research and development of therapeutic mAbs: An analysis based on pipeline projects[J]. Human Vaccines and Immunotherapeutics, 2015, 11(12), 2769-2776.
Authors:  Geng X.;  Kong X.;  Hu H.;  Chen J.;  Yang F.; et al.
Favorite | TC[WOS]:26 TC[Scopus]:31 | Submit date:2018/11/06
Development Trends  Monoclonal Antibody  Patent Citation Network  Pipeline Projects  r&d  Therapeutic Application  
Dendritic-cell-based technology landscape: Insights from patents and citation networks Journal article
Kong X., Hu Y., Cai Z., Yang F., Zhang Q.. Dendritic-cell-based technology landscape: Insights from patents and citation networks[J]. Human Vaccines and Immunotherapeutics, 2015, 11(3), 682-688.
Authors:  Kong X.;  Hu Y.;  Cai Z.;  Yang F.;  Zhang Q.
Favorite | TC[WOS]:8 TC[Scopus]:9 | Submit date:2018/12/28
Citation Network  Dendritic Cells  Immunotherapy  Patent Landscape  Patent Ownership  Patenting Strategy  Technology Development  
Dendritic-cell-based technology landscape: Insights from patents and citation networks Journal article
Kong,Xiangjun, Hu,Yuanjia, Cai,Zhifang, Yang,Fengqing, Zhang,Qianru. Dendritic-cell-based technology landscape: Insights from patents and citation networks[J]. Human Vaccines and Immunotherapeutics, 2015, 11(3), 682-688.
Authors:  Kong,Xiangjun;  Hu,Yuanjia;  Cai,Zhifang;  Yang,Fengqing;  Zhang,Qianru
Favorite | TC[WOS]:8 TC[Scopus]:9  IF:4.1/4.2 | Submit date:2021/03/01
Citation Network  Dendritic Cells  Immunotherapy  Patent Landscape  Patent Ownership  Patenting Strategy  Technology Development